• Policy
• The MFDS consulted on Expedite Approval of COVID-19 PO
• by Lee, Tak-Sun Nov 10, 2021 05:55am

• Opinion
• [Reporter’s View] Verify the oral COVID-19 treatments
• by Lee, Tak-Sun Nov 10, 2021 05:55am

• Company
• Expectations rise for Rinvoq in treating severe AD
• by Nov 10, 2021 05:55am

• Policy
• The National Assembly speeds up the telemedicine bill
• by Lee, Jeong-Hwan Nov 10, 2021 05:55am

• Company
• Ono's BTK inhibitor Velexbru was approved for sale
• by Nov 10, 2021 05:55am

• Company
• Non-reimbursed prescriptions for migraine drug Ajovy begin
• by Eo, Yun-Ho Nov 9, 2021 05:55am

• Company
• Will Ildong sell Nexium with annual sales of 50 billion won?
• by Kim, Jin-Gu Nov 9, 2021 05:54am

• Policy
• Moderna vaccine produced by SB has been applied
• by Lee, Tak-Sun Nov 9, 2021 05:53am

• Policy
• LG Chem seeks approval for its ‘Zemiglo+SGLT-2i’ combo
• by Lee, Tak-Sun Nov 9, 2021 05:53am

• Policy
• Will a recombinant flu vaccine be released in Korea, too?
• by Lee, Tak-Sun Nov 9, 2021 05:53am